Tourmaline Bio Inc.
Biotechnology
Healthcare
TRML
26.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
12.25
52 week high
29.13
high
13.05
52 week low
12.21
previous Close
12.22
P/E ratio
market cap
530 M
div yield
0
net incoming
-20.18 M
-15.38 %
net profit margin
-2017700000.00 %
0.00 %
operating incoming
-24.44 M
-11.23 %
net change in cash
-35.14 M
-24.88 %
cash on hand
35.01 M
-50.09 %
top